Management of Kawasaki disease in resource-limited settings

Pediatr Infect Dis J. 2015 Jan;34(1):94-6. doi: 10.1097/INF.0000000000000600.
No abstract available

Publication types

  • Review

MeSH terms

  • Aspirin / therapeutic use*
  • Developing Countries
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Mucocutaneous Lymph Node Syndrome / diagnosis*
  • Mucocutaneous Lymph Node Syndrome / epidemiology
  • Mucocutaneous Lymph Node Syndrome / therapy*

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Aspirin